Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

World Serine/Threonine Protein Kinase Pim 3 (Pim 3 Oncogene or PIM3 or EC 2.7.11.1) Therapeutics Pipeline Review 2016 - Research and Markets

Research and Markets
Posted on: 25 Aug 16

Research and Markets has announced the addition of the "Serine/Threonine Protein Kinase Pim 3 (Pim 3 Oncogene or PIM3 or EC 2.7.11.1) - Pipeline Review, H2 2016" drug pipelines to their offering.

This report provides comprehensive information on the therapeutic development for Serine/Threonine Protein Kinase Pim 3, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Serine/Threonine Protein Kinase Pim 3 and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Serine/Threonine Protein Kinase Pim 3 Overview
  3. Therapeutics Development
  4. Pipeline Products for Serine/Threonine Protein Kinase Pim 3 - Overview
  5. Pipeline Products for Serine/Threonine Protein Kinase Pim 3 - Comparative Analysis
  6. Serine/Threonine Protein Kinase Pim 3 - Therapeutics under Development by Companies
  7. Serine/Threonine Protein Kinase Pim 3 - Therapeutics under Investigation by Universities/Institutes
  8. Serine/Threonine Protein Kinase Pim 3 Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Serine/Threonine Protein Kinase Pim 3 - Products under Development by Companies
  13. Serine/Threonine Protein Kinase Pim 3 - Products under Investigation by Universities/Institutes
  14. Serine/Threonine Protein Kinase Pim 3 - Companies Involved in Therapeutics Development
  • Array BioPharma Inc.
  • Incyte Corporation
  • Inflection Biosciences Limited
  • Jasco Pharmaceuticals, LLC.
  • Novartis AG
  • Onconova Therapeutics, Inc.

or more information about this drug pipelines visit http://www.researchandmarkets.com/research/cfvxft/serinethreonine

Related Topics: Chemicals, Oncology Drugs, Enzymes

View source version on businesswire.com: http://www.businesswire.com/news/home/20160825006020/en/

Business Wire
www.businesswire.com

Last updated on: 25/08/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.